Advertisement
MTD vs TFX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and TFX is a StrongBuy.
MTD in upward trend: 10-day moving average moved above 50-day moving average on September 24, 2026
The 10-day moving average for MTD crossed bullishly above the 50-day moving average on September 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 65%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for MTD just turned positive on September 17, 2026. Looking at past instances where MTD's MACD turned positive, the stock continued to rise in 31 of 48 cases over the following month. The odds of a continued upward trend are 65%.
Following a +3.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTD advanced for three days, in 193 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Aroon Indicator entered an Uptrend today. In 131 of 225 cases where MTD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 58%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.
MTD broke above its upper Bollinger Band on October 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 6 (best 1 - 100 worst), indicating outstanding price growth. MTD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 87 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: MTD's P/B Ratio (2621.863) is very high in comparison to the industry average of (66.046). P/E Ratio (37.723) is within average values for comparable stocks, (2.422). Projected Growth (PEG Ratio) (2.869) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (6.798) is also within normal values, averaging (9.775).
TFX in upward trend: price rose above 50-day moving average on October 22, 2026
TFX moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 63%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 15, 2026. You may want to consider a long position or call options on TFX as a result. In 48 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for TFX just turned positive on October 01, 2026. Looking at past instances where TFX's MACD turned positive, the stock continued to rise in 32 of 51 cases over the following month. The odds of a continued upward trend are 63%.
Following a +5.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where TFX advanced for three days, in 165 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 58%.
Bearish Trend Analysis
The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TFX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
TFX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TFX entered a downward trend on October 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 16 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.902) is normal, around the industry mean (4.961). P/E Ratio (-5.657) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.165) is also within normal values, averaging (4.143). Dividend Yield (0.010) settles around the average of (0.005) among similar stocks. P/S Ratio (2.508) is also within normal values, averaging (56.876).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. TFX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TFX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
MTD | TFX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 43 | 13 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 99 Overvalued | 16 Undervalued | |
PROFIT vs RISK RATING 1..100 | 87 | 100 | |
SMR RATING 1..100 | 3 | 97 | |
PRICE GROWTH RATING 1..100 | 6 | 50 | |
P/E GROWTH RATING 1..100 | 31 | 97 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TFX's Valuation (16) in the Medical Specialties industry is significantly better than the same rating for MTD (99). This means that TFX’s stock grew significantly faster than MTD’s over the last 12 months.
MTD's Profit vs Risk Rating (87) in the Medical Specialties industry is in the same range as TFX (100). This means that MTD’s stock grew similarly to TFX’s over the last 12 months.
MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for TFX (97). This means that MTD’s stock grew significantly faster than TFX’s over the last 12 months.
MTD's Price Growth Rating (6) in the Medical Specialties industry is somewhat better than the same rating for TFX (50). This means that MTD’s stock grew somewhat faster than TFX’s over the last 12 months.
MTD's P/E Growth Rating (31) in the Medical Specialties industry is significantly better than the same rating for TFX (97). This means that MTD’s stock grew significantly faster than TFX’s over the last 12 months.
| MTD | TFX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 75% | 1 day ago 71% |
| Stochastic ODDS (%) | 1 day ago 66% | 1 day ago 68% |
| Momentum ODDS (%) | N/A | 1 day ago 58% |
| MACD ODDS (%) | 4 days ago 65% | 1 day ago 63% |
| TrendWeek ODDS (%) | 1 day ago 61% | 1 day ago 53% |
| TrendMonth ODDS (%) | 1 day ago 60% | 1 day ago 52% |
| Advances ODDS (%) | 1 day ago 61% | 7 days ago 58% |
| Declines ODDS (%) | 22 days ago 66% | 9 days ago 71% |
| BollingerBands ODDS (%) | 1 day ago 61% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 58% | 1 day ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
MTD’s FA Score shows that 3 FA rating(s) are green while TFX’s FA Score has 1 green FA rating(s).
- MTD’s FA Score: 3 green, 2 red.
- TFX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MTD’s TA Score shows that 4 TA indicator(s) are bullish while TFX’s TA Score has 4 bullish TA indicator(s).
- MTD’s TA Score: 4 bullish, 4 bearish.
- TFX’s TA Score: 4 bullish, 6 bearish.
Price Growth
MTD (@Medical Specialties) experienced а +2.78% price change this week, while TFX (@Pharmaceuticals: Other) price change was +5.77% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -3.29%. For the same industry, the average monthly price growth was -6.63%, and the average quarterly price growth was +42.53%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.
Reported Earning Dates
MTD is expected to report earnings on Nov 05, 2026.
TFX is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Medical Specialties (-3.29% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Pharmaceuticals: Other (+0.74% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
MTD and
Correlation & Price change
A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.
| Ticker / NAME | Correlation To MTD | 1D Price Change % | ||
|---|---|---|---|---|
| MTD | 100% | +0.40% | ||
| A - MTD | 68% Closely correlated | -2.17% | ||
| BRKR - MTD | 67% Closely correlated | -3.04% | ||
| TMO - MTD | 62% Loosely correlated | -2.52% | ||
| AZTA - MTD | 61% Loosely correlated | -2.04% | ||
| RGEN - MTD | 58% Loosely correlated | -0.72% | ||
More | ||||
TFX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.
| Ticker / NAME | Correlation To TFX | 1D Price Change % | ||
|---|---|---|---|---|
| TFX | 100% | +4.74% | ||
| A - TFX | 51% Loosely correlated | -2.17% | ||
| RVTY - TFX | 47% Loosely correlated | +0.48% | ||
| TNDM - TFX | 44% Loosely correlated | +4.89% | ||
| SNN - TFX | 42% Loosely correlated | +5.64% | ||
| MTD - TFX | 42% Loosely correlated | +0.40% | ||
More | ||||